Research
Topics:
INDEX
AI-chat 5
PRIME 36
PRIO 1
aging 9
brain 11
brainwave 1
cancer 11
catastrophy 1
censorship 1
climate 4
cognition 5
combat 1
covid-19 4
crime 3
culture 2
dental 2
diabetes 7
drugs 2
economy 1
energy 2
eyes 1
genetics 4
gut 1
heart 2
immune 8
law 1
metabolism 3
microbiome 1
misc 1
nutrition 6
obesity 3
pain 1
politics 4
pollution 1
practice 1
privacy 2
psychology 10
reproduction 2
rights 2
sleep 2
soc-media
space 3
unk
vaccine 5
virus 4
war-confl
war-cyber 1
 
Scanned: 3237
Evaluated: 272
Selected: 76

 
    PRIME    COVID-19    CRIME    VACCINE   

Aef30-1001

Sen. Ron Johnson Unloads Devastating Safety Data on Fauci Says COVID Shot Logged Nearly 7,000 Death Reports Per Year While FDA Ignored Warning Signs and Pushed Remdesivir

Quote: Remdesivir (69 months): 10,657 adverse events, 2,751 deaths, averaging 546 deaths per year. COVID-19 vaccines (68 months): 1,677,227 adverse events, 39,182 deaths, averaging 6,922 deaths per year. The chart also highlighted that 9,342 reported deaths occurred on days 0, 1, or 2 following COVID-19 vaccination.
Comment: A Must Read. This is just the tip of the Fauci/Covid Iceberg.
Article: https://www.thegatewaypundit.com/2026/07/sen-ron-johnson-unloads-devastating-safety-data-fauci/
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
    PRIME    COVID-19    VACCINE    VIRUS   

Mep29-005

Epidemic dynamics shape variant appearance and stochastic establishment: implications for vaccination

Quote: The relationship between the escape pressure and the vaccination coverage depends on the cross-immunity, due to susceptible depletion. For example, with intermediate cross-immunity, the risk of immune escape may be lowest at intermediate vaccination coverages. Thus, these results raise important considerations for vaccination strategies in response to novel outbreaks.
Comment: The mathematics suggest their conclusion: Intermediate levels of cross immunity have the lowest rate in which the virus evolves to create new variants which may compete with the original for hosts, aka victims.
Abstract: https://www.medrxiv.org/content/10.64898/2026.07.21.26358562v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.07.21.26358562v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Maria A. Gutierrez Julia Rose Gog, 
    DRUGS    VACCINE    VIRUS   

Sd290-038

A New Antiviral Could Stop Measles Before an Outbreak Takes Off/a

Quote: The researchers tested a recently developed drug candidate called GHP-88310 (described in Science Advances). The medication is a broad-spectrum inhibitor of the viral polymerase, an enzyme the virus needs in order to reproduce. The team examined whether prophylactic (shortly before or after exposure) use of the drug could prevent transmission through direct contact or shared air. GHP-88310 successfully blocked both forms of spread. When the drug was used to treat animals that were already infected, it also reduced the length of time they remained capable of transmitting the virus.
Comment: This is an anti-oxidant. Vitamin C works against most viruses if taken in quantity.
Article: https://www.sciencedaily.com//releases/2026/07/260724061431.htm
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
    PRIME    COVID-19    EYES    VACCINE   

Zzg29-1005

Evaluation of the Effects of mRNA-COVID 19 Vaccines on Corneal Endothelium

Quote: Conclusion: Changes in corneal endothelium occur in the short term after two-doses of the Pfizer-BioNTech (BNT162b2) COVID-19 mRNA vaccine. Hence the endothelium should be closely monitored in those with a low endothelial count or who have had a corneal graft.
Article: https://pubmed.ncbi.nlm.nih.gov/40658089/
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 

  Javilk's Research Links Newsletter for Week 30
Updated 08/01/2026-01:13:17 AM
What interests you? What have you found? Tell me!
Drop me a note to subscribe or submit something.